NL-OMON52697招募中不适用
Effectiveness of methylphenidate in children and adults with Smith Magenis syndrome and attention-deficit/hyperactivity disorder: An N-of-1 series - Methylphenidate for ADHD in Smith Magenis syndrome
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 至 99（—）
入选标准
- •- A diagnosis of SMs confirmed with standard genetic testing (such as FISH
- •test, microarray, WES-analysis).
- •- Meet DSM-5 criteria for ADHD, and diagnosed with ADHD by a multidisciplinary
- •team consisting of an intellectual disability physician, a psychologist, and a
- •psychiatrist.
- •- Minimum age of six years old.
- •- Presence of a patient*s caregiver for proxy-reports.
排除标准
- •- Presence of a contra-indication for treatment with methylphenidate.
- •- Planned general anaesthesia during the trial.
- •- Pregnancy.
- •- Breastfeeding females.
- •- Females of childbearing potential must be willing to use an effective method
- •of contraception from the time consent is signed until 6 weeks after treatment
- •discontinuation and inform the trial if pregnancy occurs.
- •- During treatment with non-selective, irreversible monoamine oxidase (MAO)
- •inhibitors, or within a minimum of 14 days of discontinuing those drugs.
- •- Current substance or alcohol abuse.
- •- Unable to swallow tablets / capsules.
研究者
相似试验
尚未招募
不适用
Methylphenidate for ADHD in Smith-Magenis syndromeSmith-Magenis syndromeADHDNL-OMON20117Amsterdam UMC6
进行中（未招募）
1 期
Methylphenidate in KBG syndromeCTIS2023-506202-40-01Stichting Radboud University Medical Center15
尚未招募
4 期
Methylphenidate in children with attention-deficit/hyperactivity disorder (ADHD) and autism (MICAA) trialAttention-deficit/hyperactivity disorderMental Health - Other mental health disordersMental Health - Autistic spectrum disordersAutism Spectrum DisorderACTRN12623001147673Professor Katrina Williams40
招募中
4 期
Methylphenidate in KBG Syndrome: N-of-1 SeriesKbg SyndromeADHD - Combined TypeNCT06465641Radboud University Medical Center15
已完成
2 期
Investigating the effectiveness of methylphenidate and combination of magnesium and zinc and calcium in treatment of patients with attention deficit hyperactivity disorder (ADHD) in Zahedan CityIRCT2015092624209N1Vice Chancellor for Research and Technology at Zahedan University of Medical Sciences and Health Ser40